Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
Clearside Biomedical logo

Clearside Biomedical

Recent Finacing

Series C

Recent Raise

$20M

Clearside Biomedical is a clinical-stage ophthalmic biopharma that develops and clinically tests suprachoroidal-space microinjector-delivered drugs for posterior-segment retinal and choroidal diseases, including CLS-TA for macular edema.

Founded 2011
Georgia, United States
11-50
Publicly Traded
clearsidebio.com

Highlights

Focus Areas

Biotechnology
Health Care
Medical Device
Pharmaceutical
Therapeutics

Recent Investors

Hatteras Venture Partners logo
Georgia Research Alliance logo
Mountain Group Partners logo
Santen Pharmaceutical logo
Cormorant Asset Management logo
Rock Springs Capital logo
Perceptive Advisors logo
AJU IB Investment logo
RusnanoMedInvest logo
Kenan Flagler Business School logo

Financials

$47.9M

Total Raised

4

Funding rounds

10

Investors